Merck & Co. (MRK)
(Delayed Data from NYSE)
$127.51 USD
-0.75 (-0.58%)
Updated May 3, 2024 03:59 PM ET
Pre-Market: $127.30 -0.21 (-0.16%) 8:44 AM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/6/24 |
---|---|
Current Quarter | 2.12 |
EPS Last Quarter | 2.07 |
Last EPS Surprise | 6.70% |
ABR | 1.26 |
Earnings ESP
|
1.10% |
---|---|
Current Year | 8.66 |
Next Year | 9.91 |
EPS (TTM) | 2.17 |
P/E (F1) | 14.73 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 15.91B | 16.71B | 64.28B | 68.81B |
# of Estimates | 7 | 7 | 6 | 7 |
High Estimate | 16.13B | 16.98B | 65.00B | 71.92B |
Low Estimate | 15.56B | 16.56B | 63.49B | 66.45B |
Year ago Sales | 15.04B | 15.96B | 60.11B | 64.28B |
Year over Year Growth Est. | 5.80% | 4.70% | 6.93% | 7.05% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.12 | 2.35 | 8.66 | 9.91 |
# of Estimates | 8 | 7 | 11 | 9 |
Most Recent Consensus | 2.03 | 2.27 | 8.58 | 9.72 |
High Estimate | 2.24 | 2.49 | 8.96 | 10.50 |
Low Estimate | 1.96 | 2.26 | 8.50 | 9.60 |
Year ago EPS | -2.06 | 2.13 | 1.51 | 8.66 |
Year over Year Growth Est. | 202.91% | 10.33% | 473.51% | 14.48% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 0 |
Up Last 30 Days | 6 | 2 | 9 | 4 |
Up Last 60 Days | 6 | 2 | 10 | 7 |
Down Last 7 Days | 0 | 0 | 0 | 1 |
Down Last 30 Days | 0 | 4 | 0 | 2 |
Down Last 60 Days | 0 | 4 | 0 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 2.12 | 2.35 | 8.66 | 9.91 |
7 Days Ago | 2.11 | 2.34 | 8.64 | 9.93 |
30 Days Ago | 1.96 | 2.36 | 8.59 | 9.84 |
60 Days Ago | 1.96 | 2.36 | 8.53 | 9.72 |
90 Days Ago | 1.96 | 2.34 | 8.50 | 9.65 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 2.15 | 2.35 | 8.69 | 9.91 |
Zacks Consensus Estimate | 2.12 | 2.35 | 8.66 | 9.91 |
Earnings ESP | 1.10% | 0.21% | 0.41% | 0.01% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.07 | 0.03 | 2.13 | -2.06 | NA |
Estimate | 1.94 | -0.09 | 1.94 | -2.17 | NA |
Difference | 0.13 | 0.12 | 0.19 | 0.11 | 0.14 |
Surprise | 6.70% | 133.33% | 9.79% | 5.07% | 38.72% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more